Visible-Light-Induced Release of Carbon Monoxide: Multifunctionally Treatment for Dry Eye Disease
Nano Letters · 2026
DOI: 10.1021/acs.nanolett.6c01749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Hongjin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen University Affiliated Xiamen Eye Center, Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China. Hauptthemen laut MEDLINE: Carbon Monoxide, Dry Eye Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Major State Basic Research Development Program of China, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Dry eye disease (DED) is a multifactorial ocular disorder driven by a reinforcing cycle of oxidative stress, inflammation, and epithelial damage, rendering single-target therapies ineffective. Here, we establish carbon monoxide (CO) gas therapy as a therapeutic modality for DED using a visible-light-activated nanoplatform, TiZr-MOF/CO@F127 (MCF), which simultaneously provides anti-inflammatory, antioxidant, and epithelial-reparative effects. A photosensitive TiZr-MOF loaded with a CO donor [BrMn(CO)5] enables controlled CO release under visible light, while the thermosensitive F127 hydrogel prolongs corneal retention. In a murine DED model, topical administration of MCF for 5 days achieved 84% corneal epithelial recovery and alleviated corneal inflammation and tissue injury. Mechanistically, CO scavenged reactive oxygen species, suppressed MMP-9 expression, promoted macrophage polarization from M1 to M2 phenotype, reduced inflammatory cytokine production, and enhanced corneal epithelial proliferation. This study establishes a light-activated CO gas therapy strategy for DED and highlights the potential of responsive nanoplatforms for ocular surface disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiamen University Affiliated Xiamen Eye Center, Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China.
- Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, Xiamen 361102, China.
- Department of Pharmacy, Xiamen Medical College, Xiamen 361023, China.
- State Key Laboratory of Physical Chemistry of Solid Surfaces and The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361002, C…
- Shen Zhen Research Institute of Xiamen University, Shenzhen 518057, China.
ORCID-Profile: Gang Liu, Chengchao Chu
Förderung
- Natural Science Foundation of Fujian Province
- Major State Basic Research Development Program of China
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Li, H., Wang, B., Chen, C., Ke, L., Ye, J., Cai, S., Han, Y., Wang, P., Liu, G., & Chu, C. (2026). Visible-Light-Induced Release of Carbon Monoxide: Multifunctionally Treatment for Dry Eye Disease. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c01749
Vancouver
Li H, Wang B, Chen C, Ke L, Ye J, Cai S, et al. Visible-Light-Induced Release of Carbon Monoxide: Multifunctionally Treatment for Dry Eye Disease. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c01749
BibTeX
@article{Li2026,
author = {Li, Hongjin and Wang, Bei and Chen, Chuan and Ke, Lang and Ye, Jinfa and Cai, Shundong and Han, Yun and Wang, Peiyu and Liu, Gang and Chu, Chengchao},
title = {Visible-Light-Induced Release of Carbon Monoxide: Multifunctionally Treatment for Dry Eye Disease},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.6c01749}
}
EUVIMED